Funds collaborative research on how vascular dysfunction contributes to cognitive impairment and dementia, with a focus on mechanisms relevant to Alzheimer’s disease and development of shared research tools.
Funder: Alzheimer's Association
Due Dates: June 15, 2026 (LOI) | September 14, 2026 (Full application)
Funding Amounts: $150,000–$300,000 total per award (max 3 years); no indirect costs allowed
Summary: Supports collaborative, high-risk research on vascular mechanisms contributing to cognitive impairment and dementia, especially as they relate to Alzheimer's disease.
Key Information: LOI is required; only one application per PI per cycle; open to U.S. and international researchers at non-profit institutions.
This program funds innovative and collaborative projects investigating how vascular dysfunction contributes to cognitive impairment and dementia, with a focus on mechanisms intersecting with Alzheimer’s disease and related disorders. Priority areas include blood-brain barrier alterations, neurovascular coupling, cerebral blood flow, waste clearance, vascular-immune crosstalk, the roles of diverse vascular and immune cell types, and intersections with immune, lipid, and endolysosomal functions. Projects developing novel biomarkers, leveraging existing datasets, or creating broadly accessible resources for neurovascular research are encouraged. All funded tools and resources must be made available to the broader scientific community.